 Home > Active Ingredient News > Antitumor Therapy > JTIM: Evaluating 17 clinically available renal biomarkers to predict acute kidney injury in critically ill patients

JTIM: Evaluating 17 clinically available renal biomarkers to predict acute kidney injury in critically ill patients

 Last Update: 2022-05-18
 Source: Internet
 Author: User

Tags

hbs antibody serum

oil serum face

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, a research paper that systematically evaluated the predictive power of 17 biomarkers of acute kidney injury

“ Assessment of 17 clinically available renal biomarkers to predict acute kidney injury in critically ill patients ”

Assessmentof 17 clinically available renal biomarkers to predict acute kidney injury in critically ill patients

Published in the fourth issue of JTIM Magazine in 2021

Hou Yating Deng Yujun Chen Chunbo Xu Feng

Research Background

Systematic estimates of renal biomarkers in intensive care unit (ICU) patients are lacking

Materials and Methods

This prospective observational study, conducted in the ICU of Guangdong Provincial People's Hospital, investigated the ability of 17 serum or urine biomarkers, alone or in combination, to predict AKI or severe AKI

result

AKI occurred in 376 (25.

in conclusion

With the exception of CysC, most clinical biomarkers or combinations of clinical markers do not significantly improve predictive power and are not cost-effective

Original source:

Yating Hou, Yujun Deng, Linhui Hu, et al.

Yating Hou, Yujun Deng, Linhui Hu, et al.
Assessment of 17 clinically available renal biomarkers to predict acute kidney injury in critically ill patients.
Journal of Translational Internal Medicine, 2022.

Leave a Comment

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Cediranib

CAS No.: 288383-20-0

$22/KG EXW

Upadacitinib hemihydrate API

CAS No.: 2050057-56-0

Pharmacy Grade

$35-45/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.